The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bromander, A.
Right arrow Articles by Lycke, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bromander, A.
Right arrow Articles by Lycke, N.

The Journal of Immunology, Vol 146, Issue 9 2908-2914, Copyright © 1991 by American Association of Immunologists

ARTICLES

Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro

A Bromander, J Holmgren and N Lycke
Department of Medical Microbiology and Immunology, University of Goteborg, Sweden.

Cholera toxin (CT) is a strong systemic and mucosal adjuvant that greatly enhances IgG and IgA immune responses. We investigated whether CT potentiates Ag presentation by macrophages as a possible mechanism underlying its adjuvant function. This was tested by preculturing APC in CT and analyzing the effect of CT treatment on the capacity to trigger 1) an allogeneic proliferative response of normal mesenteric lymph node T cells (H-2b) to the macrophage cell line P388D1 (H-2d) or 2) an Ag-specific proliferative response of D10.G4.1 clonal T cells in co-culture with normal macrophages and Ag. Pretreatment of APC, normal peritoneal macrophages or the P388D1 cells, with CT strongly enhanced Ag- and allogen-specific T cell proliferation. Also P388D1 APC treated with CT and then formalin-fixed demonstrated enhanced ability to stimulate T cell proliferation as compared to cells not exposed to CT, suggesting that the effect of CT on APC might be to enhance expression of a cell-associated factor. Flow microfluorimetry analysis of P388D1 cells cultured in CT-containing medium failed to detect an increase in class II MHC-Ag expression as compared to that found on cells not cultured in CT. In contrast, both soluble and cell-associated IL-1 formation was increased several-fold by CT, but with different CT dose requirements. A total of 10 to 100 times more CT were required for elevating the soluble IL-1 as compared to the cell associated IL-1, which was increased by as little as 1 ng/ml of CT. The soluble and cell- associated IL-1 activity induced by CT was abrogated by a polyclonal antiserum to IL-1-alpha. Similarly, the potentiating effect of CT on the ability of P388D1 APC to trigger alloreactive T cell proliferation was also blocked completely by the addition of the anti-IL-1-alpha antibody to the test system. This is the first study to demonstrate that CT potentiates Ag presentation. The mechanism for this effect probably involves induction of IL-1 production and in particular of a cell-associated form of IL-1 (IL-1-alpha). Potentiation of APC function might be important for the adjuvant action of CT on the immune response in vivo.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
C.-F. Flach, F. Qadri, T. R. Bhuiyan, N. H. Alam, E. Jennische, I. Lonnroth, and J. Holmgren
Broad Up-Regulation of Innate Defense Factors during Acute Cholera
Infect. Immun., May 1, 2007; 75(5): 2343 - 2350.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Duverger, R. J. Jackson, F. W. van Ginkel, R. Fischer, A. Tafaro, S. H. Leppla, K. Fujihashi, H. Kiyono, J. R. McGhee, and P. N. Boyaka
Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens
J. Immunol., February 1, 2006; 176(3): 1776 - 1783.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
G. Hajishengallis, S. Arce, C.M. Gockel, T.D. Connell, and M.W. Russell
Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections
J. Dent. Res., December 1, 2005; 84(12): 1104 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. K. Rouquette-Jazdanian, A. Foussat, L. Lamy, C. Pelassy, P. Lagadec, J.-P. Breittmayer, and C. Aussel
Cholera Toxin B-Subunit Prevents Activation and Proliferation of Human CD4+ T Cells by Activation of a Neutral Sphingomyelinase in Lipid Rafts
J. Immunol., November 1, 2005; 175(9): 5637 - 5648.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
N. LYCKE
ADP-Ribosylating Bacterial Enzymes for the Targeted Control of Mucosal Tolerance and Immunity
Ann. N.Y. Acad. Sci., December 1, 2004; 1029(1): 193 - 208.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. Hajishengallis, H. Nawar, R. I. Tapping, M. W. Russell, and T. D. Connell
The Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb and Their Respective B Pentamers Differentially Induce and Regulate Cytokine Production in Human Monocytic Cells
Infect. Immun., November 1, 2004; 72(11): 6351 - 6358.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. S. Riminton, R. Kandasamy, D. Dravec, A. Basten, and A. G. Baxter
Dermal Enhancement: Bacterial Products on Intact Skin Induce and Augment Organ-Specific Autoimmune Disease
J. Immunol., January 1, 2004; 172(1): 302 - 309.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Matysiak-Budnik, G. van Niel, F. Megraud, K. Mayo, C. Bevilacqua, V. Gaboriau-Routhiau, M.-C. Moreau, and M. Heyman
Gastric Helicobacter Infection Inhibits Development of Oral Tolerance to Food Antigens in Mice
Infect. Immun., September 1, 2003; 71(9): 5219 - 5224.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Eriksson, M. Fredriksson, I. Nordstrom, and J. Holmgren
Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development
Infect. Immun., April 1, 2003; 71(4): 1740 - 1747.
[Abstract] [Full Text]

Home page
 Infect. Immun.Home page
S. A. Fraser, L. de Haan, A. R. Hearn, H. K. Bone, R. J. Salmond, A. J. Rivett, N. A. Williams, and T. R. Hirst
Mutant Escherichia coli Heat-Labile Toxin B Subunit That Separates Toxoid-Mediated Signaling and Immunomodulatory Action from Trafficking and Delivery Functions
Infect. Immun., March 1, 2003; 71(3): 1527 - 1537.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
W. Jiang, H. J. Baker, and B. F. Smith
Mucosal Immunization with Helicobacter, CpG DNA, and Cholera Toxin Is Protective
Infect. Immun., January 1, 2003; 71(1): 40 - 46.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Gardby, J. Wrammert, K. Schon, L. Ekman, T. Leanderson, and N. Lycke
Strong Differential Regulation of Serum and Mucosal IgA Responses as Revealed in CD28-Deficient Mice Using Cholera Toxin Adjuvant
J. Immunol., January 1, 2003; 170(1): 55 - 63.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
M. Soriani, L. Bailey, and T. R. Hirst
Contribution of the ADP-ribosylating and receptor-binding properties of cholera-like enterotoxins in modulating cytokine secretion by human intestinal epithelial cells
Microbiology, March 1, 2002; 148(3): 667 - 676.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Burkart, Y.-E. Kim, B. Hartmann, I. Ghiea, U. Syldath, M. Kauer, W. Fingberg, P. Hanifi-Moghaddam, S. Muller, and H. Kolb
Cholera Toxin B Pretreatment of Macrophages and Monocytes Diminishes Their Proinflammatory Responsiveness to Lipopolysaccharide
J. Immunol., February 15, 2002; 168(4): 1730 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J.-Y. Wu, R. K. Taylor, and W. F. Wade
Anti-Class II Monoclonal Antibody-Targeted Vibrio cholerae TcpA Pilin: Modulation of Serologic Response, Epitope Specificity, and Isotype
Infect. Immun., December 1, 2001; 69(12): 7679 - 7686.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. F. Staats, C. P. Bradney, W. M. Gwinn, S. S. Jackson, G. D. Sempowski, H.-X. Liao, N. L. Letvin, and B. F. Haynes
Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization
J. Immunol., November 1, 2001; 167(9): 5386 - 5394.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. George-Chandy, K. Eriksson, M. Lebens, I. Nordstrom, E. Schon, and J. Holmgren
Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells
Infect. Immun., September 1, 2001; 69(9): 5716 - 5725.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. J. Smith, W. F. King, L. A. Barnes, D. Trantolo, D. L. Wise, and M. A. Taubman
Facilitated Intranasal Induction of Mucosal and Systemic Immunity to Mutans Streptococcal Glucosyltransferase Peptide Vaccines
Infect. Immun., August 1, 2001; 69(8): 4767 - 4773.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. O. Nashar, Z. E. Betteridge, and R. N. Mitchell
Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4+ T cells
Int. Immunol., April 1, 2001; 13(4): 541 - 551.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Williamson, G. M. Westrich, and J. L. Viney
Modulating Dendritic Cells to Optimize Mucosal Immunization Protocols
J. Immunol., October 1, 1999; 163(7): 3668 - 3675.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. F. Staats and F. A. Ennis Jr.
IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered with Protein Immunogens
J. Immunol., May 15, 1999; 162(10): 6141 - 6147.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. M. Pascale, M. M. Shaw, P. J. Durant, A. A. Amador, M. S. Bartlett, J. W. Smith, R. L. Gregory, and G. L. McLaughlin
Intranasal Immunization Confers Protection against Murine Pneumocystis carinii Lung Infection
Infect. Immun., February 1, 1999; 67(2): 805 - 809.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. C. Braun, J. He, C.-Y. Wu, and B. L. Kelsall
Cholera Toxin Suppresses Interleukin (IL)-12 Production and IL-12 Receptor beta 1 and beta 2 Chain Expression
J. Exp. Med., February 1, 1999; 189(3): 541 - 552.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Porgador, H. F. Staats, Y. Itoh, and B. L. Kelsall
Intranasal Immunization with Cytotoxic T-Lymphocyte Epitope Peptide and Mucosal Adjuvant Cholera Toxin: Selective Augmentation of Peptide-Presenting Dendritic Cells in Nasal Mucosa-Associated Lymphoid Tissue
Infect. Immun., December 1, 1998; 66(12): 5876 - 5881.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Sverremark and C. Fernandez
Role of T Cells and Germinal Center Formation in the Generation of Immune Responses to the Thymus-Independent Carbohydrate Dextran B512
J. Immunol., November 1, 1998; 161(9): 4646 - 4651.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. P. Matousek, J. G. Nedrud, W. Cieplak Jr., and C. V. Harding
Inhibition of Class II Major Histocompatibility Complex Antigen Processing by Escherichia coli Heat-Labile Enterotoxin Requires an Enzymatically Active A Subunit
Infect. Immun., July 1, 1998; 66(7): 3480 - 3484.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Gardby, P. Lane, and N. Y. Lycke
Requirements for B7-CD28 Costimulation in Mucosal IgA Responses: Paradoxes Observed in CTLA4-H{gamma}1 Transgenic Mice
J. Immunol., July 1, 1998; 161(1): 49 - 59.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. M. Giuliani, G. Del Giudice, V. Giannelli, G. Dougan, G. Douce, R. Rappuoli, and M. Pizza
Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
J. Exp. Med., April 6, 1998; 187(7): 1123 - 1132.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Yamamoto, H. Kiyono, M. Yamamoto, K. Imaoka, M. Yamamoto, K. Fujihashi, F. W. Van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee
A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
PNAS, May 13, 1997; 94(10): 5267 - 5272.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
S. Yamamoto, Y. Takeda, M. Yamamoto, H. Kurazono, K. Imaoka, M. Yamamoto, K. Fujihashi, M. Noda, H. Kiyono, and J. R. McGhee
Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity
J. Exp. Med., April 7, 1997; 185(7): 1203 - 1210.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.